IFG Advisory LLC Grows Stock Holdings in iShares Biotechnology ETF $IBB

IFG Advisory LLC grew its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 174.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,374 shares of the financial services provider’s stock after purchasing an additional 7,233 shares during the quarter. IFG Advisory LLC’s holdings in iShares Biotechnology ETF were worth $1,920,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at approximately $25,000. Cary Street Partners Financial LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $29,000. Copia Wealth Management purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $34,000. Cornerstone Planning Group LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $35,000. Finally, Strategic Wealth Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $35,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.0%

IBB stock opened at $172.18 on Friday. The firm’s 50 day moving average price is $169.35 and its 200-day moving average price is $170.34. iShares Biotechnology ETF has a one year low of $120.33 and a one year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.